DK135282C - Analogifremgangsmade ifolge patent nr.127113 til fremstillingaf 1,4-dihydropyridiner - Google Patents

Analogifremgangsmade ifolge patent nr.127113 til fremstillingaf 1,4-dihydropyridiner

Info

Publication number
DK135282C
DK135282C DK49571A DK49571A DK135282C DK 135282 C DK135282 C DK 135282C DK 49571 A DK49571 A DK 49571A DK 49571 A DK49571 A DK 49571A DK 135282 C DK135282 C DK 135282C
Authority
DK
Denmark
Prior art keywords
dihydropyridines
preparation
procedure according
analogical procedure
analogical
Prior art date
Application number
DK49571A
Other languages
English (en)
Other versions
DK135282B (da
Inventor
F Bossert
W Vater
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK135282B publication Critical patent/DK135282B/da
Application granted granted Critical
Publication of DK135282C publication Critical patent/DK135282C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK49571A 1970-02-05 1971-02-04 Analogifremgangsmade ifolge patent nr.127113 til fremstillingaf 1,4-dihydropyridiner DK135282C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2005116A DE2005116C3 (de) 1970-02-05 1970-02-05 Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester

Publications (2)

Publication Number Publication Date
DK135282B DK135282B (da) 1977-03-28
DK135282C true DK135282C (da) 1977-08-15

Family

ID=5761434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK49571A DK135282C (da) 1970-02-05 1971-02-04 Analogifremgangsmade ifolge patent nr.127113 til fremstillingaf 1,4-dihydropyridiner

Country Status (17)

Country Link
US (1) US4048171A (da)
JP (1) JPS5550021B1 (da)
AT (1) AT302302B (da)
BE (1) BE762580A (da)
CA (1) CA944768A (da)
CH (1) CH553780A (da)
CS (1) CS161771B2 (da)
DE (1) DE2005116C3 (da)
DK (1) DK135282C (da)
ES (1) ES387973A1 (da)
FR (1) FR2150555B1 (da)
GB (2) GB1328479A (da)
IE (1) IE34896B1 (da)
IL (1) IL36018A0 (da)
NL (1) NL171580C (da)
YU (1) YU18471A (da)
ZA (1) ZA71438B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1430961A (en) * 1972-01-22 1976-04-07 Yamanouchi Pharma Co Ltd 1-substituted-1,4-dihyddrypyridine derivatives
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
GB1426499A (en) * 1973-10-02 1976-02-25 I Organischeskogo Sinteza Akad Pharmaceutical composition for treating liver diseases
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
FR2405937A1 (fr) * 1977-10-14 1979-05-11 Labaz Nouveaux derives de dihydropyridine, leur procede de preparation et leur application
DE2844130A1 (de) * 1977-10-14 1979-04-26 Labaz Neue dihydropyridine und deren verwendung
DE3021958A1 (de) * 1980-06-12 1981-12-24 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
DE3432563A1 (de) * 1984-09-05 1986-03-13 Bayer Ag, 5090 Leverkusen Neue pyridylethyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5202330A (en) * 1985-06-03 1993-04-13 E. R. Squibb & Sons, Inc. 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters
DE3677319D1 (de) * 1985-10-22 1991-03-07 Sanwa Kagaku Kenkyusho Co Pharmazeutische 1,4-dihydropyridinderivate, ihre salze und herstellung.
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
US4753946A (en) * 1987-04-08 1988-06-28 E. R. Squibb & Sons, Inc. Pyrimidinecarboxylic acid derivatives
US5216172A (en) * 1988-02-24 1993-06-01 Ajinomoto Co., Inc. 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cells
EP0330470A3 (en) * 1988-02-24 1992-01-02 Ajinomoto Co., Inc. 1,4-dihydropyridine derivatives useful against tumour cells
US6066642A (en) * 1996-01-29 2000-05-23 The United States Of America As Represented By The Department Of Health And Human Services Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
AU2603197A (en) 1996-04-10 1997-10-29 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
US6376521B1 (en) 1998-07-10 2002-04-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services A3 adenosine receptor antagonists
CA2397366C (en) * 2000-01-14 2011-03-15 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methanocarba cycloalkyl nucleoside analogues
WO2011068978A1 (en) 2009-12-02 2011-06-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325505A (en) * 1965-02-24 1967-06-13 Smith Kline French Lab 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
US3511847A (en) * 1967-02-07 1970-05-12 Smithkline Corp 2,6-di-lower alkyl - 1,4-dihydro - 4-(2-trifluoromethylphenyl) - 3,5 - pyridinedicarboxylic acid esters
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
US3455939A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(4-chloro-3-sulfamoylphenyl)-1,4-dihydropyridines
DE1813436C3 (de) * 1968-12-07 1979-01-11 Bayer Ag, 5090 Leverkusen N-Substituierte 2,6-Dimethyl-l,4dihydropyridine
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate

Also Published As

Publication number Publication date
GB1328479A (en) 1973-08-30
IE34896B1 (en) 1975-09-17
IE34896L (en) 1971-08-05
ZA71438B (en) 1971-10-27
ES387973A1 (es) 1974-01-16
NL7101234A (da) 1971-08-09
DE2005116B2 (de) 1979-06-07
BE762580A (fr) 1971-08-05
NL171580C (nl) 1983-04-18
GB1326491A (en) 1973-08-15
CA944768A (en) 1974-04-02
CH553780A (de) 1974-09-13
IL36018A0 (en) 1971-03-24
DE2005116A1 (de) 1971-09-02
CS161771B2 (da) 1975-06-10
YU18471A (en) 1978-12-31
US4048171A (en) 1977-09-13
NL171580B (nl) 1982-11-16
JPS5550021B1 (da) 1980-12-16
FR2150555B1 (da) 1974-09-06
AT302302B (de) 1972-10-10
DK135282B (da) 1977-03-28
DE2005116C3 (de) 1980-02-14
FR2150555A1 (da) 1973-04-13

Similar Documents

Publication Publication Date Title
DK135282C (da) Analogifremgangsmade ifolge patent nr.127113 til fremstillingaf 1,4-dihydropyridiner
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
DK143799C (da) Fremgangsmaade til fremstilling af n-1,1,1-trisubstituerede methylazoler
DK132174C (da) Analogifremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
SE384368B (sv) Forfarande for framstellning av 6-substituerade - 4 - amino- 1,2 - dihydro - 1 - hydroxi - 2 - iminopyrimidiner
FI49503C (fi) Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi.
DK123357B (da) Analogifremgangsmåde til fremstilling af N(6)-benzyl-adenosin-derivater.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK136612C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-4-pregnen-21-syrederivater
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
DK130295B (da) Fremgangsmåde til fremstilling af 5-imino-1,2,4-triazinderivater.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
DK124130B (da) Fremgangsmåde til fremstilling af ren hexetidin.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
SE380263B (sv) Forfarande for framstellning av 10-oxo-7,10-dihydro-1h-dioxino-(5,4-f)-9-kinolyl-karbonsyror
DK132831C (da) Analogifremgangsmade til fremstilling af 17beta-hydroxy-2,2,17-trimethyl-4-androsten-3-on
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK135131C (da) Analogifremgangsmade til fremstilling af 6alfa,16alfa-dimethyl-1,4-pregnadien-3,20-dioner
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
DK132121C (da) Fremgangsmade til fremstilling af 17alfa-hydroxypregna-4,9(11)-dien-3,20-dion